Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0X2RL
|
||||
Former ID |
DNCL003810
|
||||
Drug Name |
LY3012212
|
||||
Synonyms |
Icrucumab
|
||||
Indication | Arteriosclerosis; Bladder cancer [ICD9: 440, 188; ICD10:I70, C67] | Phase 2 | [548347] | ||
Company |
Lilly
|
||||
Target and Pathway | |||||
Target(s) | Vascular endothelial growth factor receptor 1 | Target Info | Modulator | [532445] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.